posted a narrower-than-expected third-quarter loss helped by solid increases in revenue, gross margins and repeat orders.
The online drugstore and information site posted a loss of $33.3 million, or 58 cents a share, excluding amortization of intangible assets and stock-based compensation. Ten analysts polled by
First Call/Thomson Financial
expected a third-quarter loss of 64 cents a share.
Sales for the quarter rose to $26.5 million from $12.2 million last year. The company also said it expects fourth-quarter sales to range from about $29 million to $30 million, in line with current Wall Street consensus forecasts. The company expects sales of $135 million to $145 million for 2001.